BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cell & Gene

Breaking Down Portal Fatigue in Cell and Gene Therapy: Insights from TrakCel’s Experts

In this exclusive BioPharma APAC Q&A, Dr. Matthew Lakelin, Co-Founder and Head of Consultancy Services at TrakCel, and Antonios Spanos, Industry Adviso...

October 17, 2024 | Interview

Astellas Secures Exclusive Option for AVB-101 Gene Therapy in $2.18 Billion Deal with AviadoBio

Astellas receives an exclusive option to license AVB-101, an investigational, AAV-based gene therapy in Phase 1/2 development Av...

October 11, 2024 | News

Andelyn Biosciences to Manufacture AAV for Hubble Therapeutics' Gene Therapy Targeting Rare Eye Disease

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selecte...

October 11, 2024 | News

Bio-Rad Launches Vericheck ddPCR™ Kit for Precise AAV Vector Quality Assessment

Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics products, announced the launch of the Vericheck ddPCR™ Empty-...

October 09, 2024 | News

Ascend Advanced Therapies Expands Gene Therapy Manufacturing with AST's GENiSYS® C Fill-Finish System

AST, a leading provider of flexible aseptic filling systems, has announced the placement of a next-generation GENiSYS® C fill-finish system&n...

October 04, 2024 | News

Minovia Therapeutics Receives FDA Clearance to Initiate Phase Ib Trial for Mitochondrial Cell Therapy in Low-Risk MDS Patients

MNV-201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria In pre-clini...

September 27, 2024 | News

Belief BioMed and AskBio Forge Strategic Collaboration to Advance Liver-Targeted Gene Therapies

Belief BioMed and AskBio will work together to advance potential gene therapies in diseases with high unmet medical need, using a liver-targeted approach...

September 26, 2024 | News

CD Biopharma Receives FDA Clearance for IND Application of CD-001, Paving the Way for Phase I Clinical Trial

CD (Suzhou) Biopharma has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application...

September 23, 2024 | News

Nona Biosciences and Umoja Biopharma Partner to Advance Next-Generation CAR-T Cell Therapies

Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), announced that it has entered into a multi...

September 13, 2024 | News

NextPoint Therapeutics Introduces NPX372, a Novel T Cell Engager Targeting B7-H7 Axis in Solid Tumors

NextPoint Therapeutics, a clinical-stage biotechnology company developing a new class of precision immuno-oncology and tumor-directed therapeutics targetin...

September 09, 2024 | News

Arsenal Biosciences Closes $325 Million Series C Funding to Advance Next-Gen CAR T-Cell Therapies for Solid Tumors

Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid t...

September 05, 2024 | News

Skyline Therapeutics Secures FDA Orphan Drug Designation for Gene Therapy SKG1108 to Treat Retinitis Pigmentosa

Skyline Therapeutics, an innovation-driven gene therapy company committed to developing unique and novel solutions for rare and severe diseases, announced ...

September 04, 2024 | News

Acepodia Partners with Pfizer Ignibiolote to Advance Cell Therapies for Autoimmune Diseases and Oncology

Through Pfizer Ignite, Acepodia will gain access to Pfizer's resources, scale and expertise as the company broadens the application of its platform beyon...

September 04, 2024 | News

PHC Corporation Debuts LiCellGrow Prototype for Enhanced Cell & Gene Therapy Production

-PHC Corporation Biomedical Division (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura, hereinafter referred to as the "Biomedical Divisio...

September 03, 2024 | News

Stay Connected